Clinical Trial Update: Study to Evaluate the Effect of BYDUREON on 24-hour Glucose Control in Metformin Treated Patients With Type 2 Diabetes. [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating BYDUREON on 24-hour glucose control in metformin-treated type 2 diabetes patients; the study is completed with results posted January 2…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Bydureon (exenatide)

Snippet

Sponsor: AstraZeneca | Conditions: Type 2 Diabetes | Phase 4 | Status: COMPLETED | Results posted: 2017-01-27